Cytoskeleton & Motor Proteins
Products Related to Cytoskeleton & Motor Proteins(68)
- GC52192(S)-4'-nitro-BlebbistatinCAS: 1621326-32-6Purity: >99.50%
(S)-4'-nitro-Blebbistatin is a non-cytotoxic, photostable, fluorescent and specific Myosin II inhibitor, usd in the study of the specific role of myosin II in physiological, developmental, and cell biological studies.
- GC52367Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin PeptidePurity: >99.00%
A biotinylated and citrullinated mutant vimentin peptide
- GC52370Citrullinated Vimentin (R144) (139-159)-biotin PeptidePurity: >98.00%
A biotinylated and citrullinated vimentin peptide
- GC52371Vimentin (G146R) (139-159)-biotin PeptidePurity: >98.00%
A biotinylated mutant vimentin peptide
- GC60120DanicamtivCAS: 1970972-74-7Purity: >99.00%
Danicamtiv (MYK-491), an inotropic agent, is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.
- GC639586α-Hydroxy Paclitaxel-d5CAS: 1315376-90-9Purity: >98%
6α-Hydroxy Paclitaxel-d5 is the deuterium labeled 6α-Hydroxy paclitaxel. 6α-Hydroxy paclitaxel is a primary metabolite of Paclitaxel. 6α-Hydroxy paclitaxel retains a time-dependent effect on organic anion-transporting polypeptides 1B1/SLCO1B1 (OATP1B1) with similar inhibition potency to Paclitaxel, whereas it no longer showed time-dependent inhibition of OATP1B3. 6α-Hydroxy paclitaxel can be used for the research of cancer.
- GC81526Delpacibart zotadirsenCAS: 2929240-20-8Purity: >92.50%
Delpacibart zotadirsen (Del-zota), an antibody oligonucleotide conjugate (AOC), consists of a monoclonal antibody (Delpacibart) that binds to the transferrin receptor 1 (TfR1) conjugated to a phosphorodiamidate morpholino conjugate (PMO), Delpacibart zotadirsen is designed to deliver phosphorodiamidate morpholino oligomers (PMOs) to skeletal muscle and heart tissue to specifically skip exon 44 of the dystrophin gene and enable production of near-full length dystrophin.
- GC81534MMA-NODAGA TFAPurity: >98.00%
MMA-NODAGA TFA is a chelator for site-specific labeling of targeting proteins containing unpaired cysteine.
- GC81614ZotadirsenPurity: >98.00%
Zotadirsen is the core component of the AOC drug Delpacibart zotadirsen (AOC1044), consisting of a phosphorodiamidate morpholino oligonucleotide (PMO) targeting exon 44 of the dystrophin gene and an SMCC linker.
- GC90733Klotho-derived Peptide 1 (56-87) (human) (trifluoroacetate salt)Purity: >95.00%
A TGF-β disrupting peptide
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49913 | Davunetide (acetate) | - | >98.00% | |
A neuroprotective ADNP-derived peptide | ||||
| GC52029 | 2-Aminoflubendazole | 82050-13-3 | >95.00% | |
| GC52192 | (S)-4'-nitro-Blebbistatin | 1621326-32-6 | >99.50% | |
(S)-4'-nitro-Blebbistatin is a non-cytotoxic, photostable, fluorescent and specific Myosin II inhibitor, usd in the study of the specific role of myosin II in physiological, developmental, and cell biological studies. | ||||
| GC52364 | Vimentin (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated vimentin peptide | ||||
| GC52367 | Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide | - | >99.00% | |
A biotinylated and citrullinated mutant vimentin peptide | ||||
| GC52370 | Citrullinated Vimentin (R144) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated and citrullinated vimentin peptide | ||||
| GC52371 | Vimentin (G146R) (139-159)-biotin Peptide | - | >98.00% | |
A biotinylated mutant vimentin peptide | ||||
| GC60120 | Danicamtiv | 1970972-74-7 | >99.00% | |
Danicamtiv (MYK-491), an inotropic agent, is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency. | ||||
| GC63958 | 6α-Hydroxy Paclitaxel-d5 | 1315376-90-9 | >98% | |
6α-Hydroxy Paclitaxel-d5 is the deuterium labeled 6α-Hydroxy paclitaxel. 6α-Hydroxy paclitaxel is a primary metabolite of Paclitaxel. 6α-Hydroxy paclitaxel retains a time-dependent effect on organic anion-transporting polypeptides 1B1/SLCO1B1 (OATP1B1) with similar inhibition potency to Paclitaxel, whereas it no longer showed time-dependent inhibition of OATP1B3. 6α-Hydroxy paclitaxel can be used for the research of cancer. | ||||
| GC74326 | MPSD TFA | - | >98.00% | |
MPSD TFA (MARCKS-ED TFA) is the TFA salt form of MPSD. | ||||
| GC81526 | Delpacibart zotadirsen | 2929240-20-8 | >92.50% | |
Delpacibart zotadirsen (Del-zota), an antibody oligonucleotide conjugate (AOC), consists of a monoclonal antibody (Delpacibart) that binds to the transferrin receptor 1 (TfR1) conjugated to a phosphorodiamidate morpholino conjugate (PMO), Delpacibart zotadirsen is designed to deliver phosphorodiamidate morpholino oligomers (PMOs) to skeletal muscle and heart tissue to specifically skip exon 44 of the dystrophin gene and enable production of near-full length dystrophin. | ||||
| GC81534 | MMA-NODAGA TFA | - | >98.00% | |
MMA-NODAGA TFA is a chelator for site-specific labeling of targeting proteins containing unpaired cysteine. | ||||
| GC81554 | CP05 | 1824650-30-7 | >97.00% | |
CP05 is a peptide that specifically recognizes an exosome surface marker ( CD63 ). | ||||
| GC81555 | GPLGVRGC | 1257658-47-1 | >98.00% | |
GPLGVRG C is a cysteine-tagged variant of GPLGVRG. | ||||
| GC81614 | Zotadirsen | - | >98.00% | |
Zotadirsen is the core component of the AOC drug Delpacibart zotadirsen (AOC1044), consisting of a phosphorodiamidate morpholino oligonucleotide (PMO) targeting exon 44 of the dystrophin gene and an SMCC linker. | ||||
| GC90669 | Negamycin (hydrochloride) | - | >80.00% | |
An antibiotic | ||||
| GC90733 | Klotho-derived Peptide 1 (56-87) (human) (trifluoroacetate salt) | - | >95.00% | |
A TGF-β disrupting peptide | ||||
| GC90981 | Lipid 10 | 2430034-02-7 | >95.00% | |
An ionizable cationic lipid | ||||
| GC91096 | S-72 | 2446799-14-8 | >98.00% | |
An inhibitor of microtubule polymerization | ||||
| GC91228 | SSE1806 | - | >95.00% | |
A microtubule destabilizer | ||||